Fifth Third Bancorp Spectrum Pharmaceuticals Inc Transaction History

Fifth Third Bancorp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$0.63 - $1.59 $741 - $1,871	-1,177 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$1.27 - $2.42 $1,494 - $2,848	1,177 New	1,177 $1,000
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $13,107 - $19,923	-916 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $1,512 - $2,168	-94 Reduced 9.31%	916 $15,000
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $8,837 - $14,210	1,010	1,010 $14,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.